{
    "code": "02024933",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024933",
    "time": "2021-11-12 03:20:05",
    "許可證字號": "衛署藥輸字第024933號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "112\/12\/09",
    "發證\/登錄日期": "97\/12\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202493301",
    "中文品名": "紐普洛穿皮貼片劑 2 毫克\/ 24 小時",
    "英文品名": "Neupro Transdermal Patch 2mg\/24h",
    "適應症": "原發性帕金森氏症。",
    "劑型": "327穿皮貼片劑",
    "包裝": "2~1000片鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ROTIGOTINE",
    "限制項目": "02輸　入 58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "620101S739  台灣優時比貿易有限公司",
    "申請商地址": "台北市松山區敦化北路88號12樓之2",
    "主製造廠": [
        {
            "": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FDE0550100  AESICA PHARMACEUTICALS Gmb",
            "製造廠廠址": "MITTELSTRASSE 15, D-40789 MONHEIM AM RHEIN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FIE0044000  UCB Manufacturing Ireland Limited",
            "製造廠廠址": "SHANNON INDUSTRIAL ESTATE, SHANNON, CO CLARE, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9602093400",
            "成分名稱": "ROTIGOTINE",
            "含量描述": "",
            "含量": "4.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "8014972-4535-CIA79871B+-+PCH+FS+NEUPRO+2MG+PAT+RT+TW-107-05-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024933&Seq=003&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI- Neupro-2021 Patient-cn rev-110-09-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024933&Seq=021&Type=9"
        },
        {
            "title": "Rotigotine-PI (final)-110-09-02.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024933&Seq=020&Type=9"
        },
        {
            "title": "CIA79042B+-+4021286+-BOX+NEUPRO+2MG+28PAT+RT+TW-107-05-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024933&Seq=003&Type=8"
        }
    ]
}